华西研究精选混合发起C
(025471)公募混合型
重仓股明细
查询指定年度的基金持仓:
| 季报日期: 2026-03-31 |
| 序号 |
股票代码 |
股票名称 |
占净值比例 |
持股数量(万股) |
持股市值(万元) |
占股票市值比例(季报) |
持仓变动 |
| 1 |
300677 |
英科医疗 |
9.04% |
3.85 |
225.92 |
0.01% |
新增 |
| 2 |
002821 |
凯莱英 |
7.00% |
1.58 |
175.02 |
0.01% |
-0.54 (-34.18%) |
| 3 |
603259 |
药明康德 |
6.91% |
1.76 |
172.66 |
0.00% |
0.26 (14.77%) |
| 4 |
688221 |
前沿生物 |
5.92% |
7.80 |
147.89 |
0.02% |
新增 |
| 5 |
002294 |
信立泰 |
5.76% |
2.35 |
144.08 |
0.00% |
新增 |
| 6 |
300759 |
康龙化成 |
5.63% |
5.03 |
140.74 |
0.00% |
新增 |
| 7 |
01530 |
三生制药 |
5.60% |
7.00 |
139.93 |
0.00% |
0.15 (2.14%) |
| 8 |
002653 |
海思科 |
4.71% |
2.17 |
117.79 |
0.00% |
新增 |
| 9 |
301333 |
诺思格 |
4.37% |
1.59 |
109.15 |
0.02% |
-1.14 (-71.70%) |
| 10 |
03347 |
泰格医药 |
4.11% |
2.81 |
102.82 |
0.02% |
1.03 (36.65%) |
| 季报日期: 2026-03-31 |
| 序号 |
股票代码 |
股票名称 |
占净值比例 |
持股数量(万股) |
持股市值(万元) |
占股票市值比例(季报) |
持仓变动 |
| 1 |
300677 |
英科医疗 |
9.04% |
3.85 |
225.92 |
0.01% |
新增 |
| 2 |
002821 |
凯莱英 |
7.00% |
1.58 |
175.02 |
0.01% |
-0.54 (-34.18%) |
| 3 |
603259 |
药明康德 |
6.91% |
1.76 |
172.66 |
0.00% |
0.26 (14.77%) |
| 4 |
688221 |
前沿生物 |
5.92% |
7.80 |
147.89 |
0.02% |
新增 |
| 5 |
002294 |
信立泰 |
5.76% |
2.35 |
144.08 |
0.00% |
新增 |
| 6 |
300759 |
康龙化成 |
5.63% |
5.03 |
140.74 |
0.00% |
新增 |
| 7 |
01530 |
三生制药 |
5.60% |
7.00 |
139.93 |
0.00% |
0.15 (2.14%) |
| 8 |
002653 |
海思科 |
4.71% |
2.17 |
117.79 |
0.00% |
新增 |
| 9 |
301333 |
诺思格 |
4.37% |
1.59 |
109.15 |
0.02% |
-1.14 (-71.70%) |
| 10 |
03347 |
泰格医药 |
4.11% |
2.81 |
102.82 |
0.02% |
1.03 (36.65%) |
显示全部持仓明细>>
| 季报日期: 2025-12-31 |
| 序号 |
股票代码 |
股票名称 |
占净值比例 |
持股数量(万股) |
持股市值(万元) |
占股票市值比例(季报) |
持仓变动 |
| 1 |
688621 |
阳光诺和 |
10.02% |
5.10 |
316.99 |
14.88% |
0.00 (0.00%) |
| 2 |
01801 |
信达生物 |
7.51% |
3.45 |
237.60 |
11.15% |
-2.55 (-73.91%) |
| 3 |
002821 |
凯莱英 |
6.22% |
2.12 |
197.01 |
9.25% |
新增 |
| 4 |
01093 |
石药集团 |
6.11% |
25.40 |
193.40 |
9.08% |
-27.40 (-107.87%) |
| 5 |
301333 |
诺思格 |
5.14% |
2.73 |
162.57 |
7.63% |
新增 |
| 6 |
301257 |
普蕊斯 |
5.10% |
3.10 |
161.32 |
7.57% |
新增 |
| 7 |
01530 |
三生制药 |
4.73% |
6.85 |
149.60 |
7.02% |
-7.45 (-108.76%) |
| 8 |
603259 |
药明康德 |
4.30% |
1.50 |
135.96 |
6.38% |
新增 |
| 9 |
600521 |
华海药业 |
4.27% |
7.97 |
135.25 |
6.35% |
-5.80 (-72.77%) |
| 10 |
688607 |
康众医疗 |
3.18% |
2.35 |
100.55 |
4.72% |
新增 |
| 季报日期: 2025-12-31 |
| 序号 |
股票代码 |
股票名称 |
占净值比例 |
持股数量(万股) |
持股市值(万元) |
占股票市值比例(季报) |
持仓变动 |
| 1 |
688621 |
阳光诺和 |
10.02% |
5.10 |
316.99 |
14.88% |
0.00 (0.00%) |
| 2 |
01801 |
信达生物 |
7.51% |
3.45 |
237.60 |
11.15% |
-2.55 (-73.91%) |
| 3 |
002821 |
凯莱英 |
6.22% |
2.12 |
197.01 |
9.25% |
新增 |
| 4 |
01093 |
石药集团 |
6.11% |
25.40 |
193.40 |
9.08% |
-27.40 (-107.87%) |
| 5 |
301333 |
诺思格 |
5.14% |
2.73 |
162.57 |
7.63% |
新增 |
| 6 |
301257 |
普蕊斯 |
5.10% |
3.10 |
161.32 |
7.57% |
新增 |
| 7 |
01530 |
三生制药 |
4.73% |
6.85 |
149.60 |
7.02% |
-7.45 (-108.76%) |
| 8 |
603259 |
药明康德 |
4.30% |
1.50 |
135.96 |
6.38% |
新增 |
| 9 |
600521 |
华海药业 |
4.27% |
7.97 |
135.25 |
6.35% |
-5.80 (-72.77%) |
| 10 |
688607 |
康众医疗 |
3.18% |
2.35 |
100.55 |
4.72% |
新增 |
| 11 |
002773 |
康弘药业 |
2.22% |
2.34 |
70.13 |
3.29% |
--- |
| 12 |
03347 |
泰格医药 |
2.16% |
1.78 |
68.39 |
3.21% |
--- |
| 13 |
01877 |
君实生物 |
1.99% |
3.26 |
62.84 |
2.95% |
--- |
| 14 |
02269 |
药明生物 |
1.84% |
2.05 |
58.21 |
2.73% |
--- |
| 15 |
000989 |
九芝堂 |
1.54% |
5.60 |
48.89 |
2.29% |
--- |
| 16 |
688212 |
澳华内镜 |
1.01% |
0.73 |
32.00 |
1.50% |
--- |
| 17 |
06606 |
诺辉健康 |
0.00% |
3.75 |
0.03 |
0.00% |
--- |
显示全部持仓明细>>
| 季报日期: 2025-09-30 |
| 序号 |
股票代码 |
股票名称 |
占净值比例 |
持股数量(万股) |
持股市值(万元) |
占股票市值比例(季报) |
持仓变动 |
| 1 |
01801 |
信达生物 |
10.08% |
6.00 |
528.07 |
0.00% |
--- |
| 2 |
688266 |
泽璟制药 |
9.84% |
4.56 |
515.35 |
0.02% |
--- |
| 3 |
01093 |
石药集团 |
8.62% |
52.80 |
451.68 |
0.00% |
--- |
| 4 |
01530 |
三生制药 |
7.48% |
14.30 |
391.67 |
0.01% |
--- |
| 5 |
688621 |
阳光诺和 |
6.43% |
5.10 |
336.83 |
0.05% |
--- |
| 6 |
600521 |
华海药业 |
5.57% |
13.77 |
291.79 |
0.01% |
--- |
| 7 |
603108 |
润达医疗 |
5.28% |
17.28 |
276.48 |
0.03% |
--- |
| 8 |
000513 |
丽珠集团 |
4.79% |
6.52 |
250.69 |
0.01% |
--- |
| 9 |
02228 |
晶泰控股 |
4.46% |
18.00 |
233.69 |
0.00% |
--- |
| 10 |
00512 |
远大医药 |
4.23% |
28.50 |
221.69 |
0.01% |
--- |
| 季报日期: 2025-09-30 |
| 序号 |
股票代码 |
股票名称 |
占净值比例 |
持股数量(万股) |
持股市值(万元) |
占股票市值比例(季报) |
持仓变动 |
| 1 |
01801 |
信达生物 |
10.08% |
6.00 |
528.07 |
0.00% |
--- |
| 2 |
688266 |
泽璟制药 |
9.84% |
4.56 |
515.35 |
0.02% |
--- |
| 3 |
01093 |
石药集团 |
8.62% |
52.80 |
451.68 |
0.00% |
--- |
| 4 |
01530 |
三生制药 |
7.48% |
14.30 |
391.67 |
0.01% |
--- |
| 5 |
688621 |
阳光诺和 |
6.43% |
5.10 |
336.83 |
0.05% |
--- |
| 6 |
600521 |
华海药业 |
5.57% |
13.77 |
291.79 |
0.01% |
--- |
| 7 |
603108 |
润达医疗 |
5.28% |
17.28 |
276.48 |
0.03% |
--- |
| 8 |
000513 |
丽珠集团 |
4.79% |
6.52 |
250.69 |
0.01% |
--- |
| 9 |
02228 |
晶泰控股 |
4.46% |
18.00 |
233.69 |
0.00% |
--- |
| 10 |
00512 |
远大医药 |
4.23% |
28.50 |
221.69 |
0.01% |
--- |
显示全部持仓明细>>